ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: Prana Biotechnology Limited

Data Safety Monitoring Board gives OK to Prana for Imagine Trial for Alzheimer’s

Data Safety Monitoring Board gives OK to Prana for Imagine Trial for Alzheimer’s

September 12, 2012 9:07 am by | 4 Comments

Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today reported that it had received a recommendation from the Data Safety Monitoring Board (DSMB) that the IMAGINE trial for Alzheimer's disease should continue ... Read more
Prana’s Parkinson’s drug meets foundation’s toxicology, genotoxicity and safety milestones

Prana’s Parkinson’s drug meets foundation’s toxicology, genotoxicity and safety milestones

August 29, 2012 10:22 am by | 0 Comments

Prana Biotechnology Limited (NASDAQ: PRAN) announced today that its lead compound in development for Parkinson's disease (PD), PBT434, had progressed successfully though a series of preclinical development studies used to ... Read more